Net sales of $200.3 million, an increase of 64% on a reported basis and an increase of 8% on a pro forma basis
Bone Growth Therapies growth of 15%, marking four consecutive quarters with.
Orthofix Medical Inc Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
Orthofix Medical: Under New Management (NASDAQ:OFIX) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Nevro. Corp. closed the acquisition of privately held Vyrsa Technologies Inc., adding the company’s V1 implant for sacroiliac (SI) joint fusion to its product line for chronic pain. Nevro paid $40 million at closing and agreed to up to $35 million in additional payments contingent on the achievement of certain development and sales milestones.
Operator: Hello. Good afternoon, and welcome to the Orthofix Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.